SCHEMBL23012198

SCHEMBL23012198

CCOC(=O)c1cc(-c2nc3cc(-c4cnn(C(C)C)c4)ccc3o2)ccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPSE Q9Y251 1/20 0.40
▸ MAPT P10636 6/20 0.38
▸ RAB9A P51151 6/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ HPGD P15428 5/20 0.38
▸ HSD17B10 Q99714 5/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ MAPK1 P28482 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ TP53 P04637 3/20 0.38
▸ TSHR P16473 2/20 0.38
▸ CASP3 P42574 2/20 0.38
▸ SENP8 Q96LD8 2/20 0.38
▸ SENP7 Q9BQF6 2/20 0.38
▸ SENP6 Q9GZR1 2/20 0.38
▸ NPC1 O15118 5/20 0.38
▸ SYK P43405 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29479730 1.00 HPSE (0.40) HPSEMAPTRAB9AALDH1A1HPGD
SCHEMBL29479641 0.88 PIM1 (0.44) HPSEMAPTRAB9AALDH1A1HPGD
SCHEMBL28714674 0.88 PIM1 (0.44) HPSEMAPTRAB9AALDH1A1HPGD
SCHEMBL29479608 0.87 ABL1 (0.41) HPSEMAPTRAB9AALDH1A1HPGD
SCHEMBL28713388 0.87 ABL1 (0.41) HPSEMAPTRAB9AALDH1A1HPGD
SCHEMBL28706416 0.87 MAOA (0.43) HPSERAB9AALDH1A1HPGDHSD17B10
SCHEMBL29479615 0.87 MAOA (0.43) HPSERAB9AALDH1A1HPGDHSD17B10
SCHEMBL28706341 0.86 CASP3 (0.39) HPSEMAPTRAB9AALDH1A1HPGD
SCHEMBL23012163 0.84 GRK5 (0.45) —
SCHEMBL29479765 0.84 GRK5 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269725-A Anti-influenza virus compound and preparation method and application thereof 四川海思科制药有限公司 2022-04-01 — — CN disclosed
WO-2021032209-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF 四川海思科制药有限公司 2021-02-25 — — WO disclosed
Send feedback